Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Dr. med. Tanja Trarbach

Funktionen

  • Mitglied/er, Innere Klinik (Tumorforschung)

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Stahler, Arndt; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; Fischer von Weikersthal, Ludwig; Caca, Karel; Goekkurt, Eray; Ballhausen, Alexej; Sommerhäuser, Greta; Alig, Annabel H.S.; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P.
    Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212) : final efficacy analysis of a randomised, open-label, phase 2 trial
    In: eClinicalMedicine , Jg. 79 2025, 103004
    DOI (Open Access)
  • Griesinger, Frank; Sebastian, Martin; Brueckl, Wolfgang M.; Hummel, Horst-Dieter; Jaeschke, Bastian; Kern, Jens; Wesseler, Claas; Jänicke, Martina; Fleitz, Annette; Zacharias, Stefan; Hipper, Annette; Groth, Annika; Weichert, Wilko; Dörfel, Steffen; Petersen, Volker; Schröder, Jan; Wilke, Jochen; Eberhardt, Wilfried; Thomas, Michael; Ababei, Juliana; Alt, Jürgen; Ammon, Andreas; Anhuf, Jürgen; Azeh, Ivo; Bauer, Stefan; Behringer, Dirk; Berger, Winfried; Bernhardt, Christiane; Bertram, Mathias; Boesche, Michael; Bohnet, Sabine; Bruch, Harald-Robert; Brückl, Wolfgang; Burkhard-Meier, Ulrike; Christopoulos, Petros; Däßler, Klaus-Ulrich; de Wit, Maike; Dechow, Tobias; Depenbusch, Reinhard; Dietze, Lutz; Dommach, Markus; Eberhardt, Wilfried; Elender, Corinna; Elsel, Wolfgang; Emde, Till-Oliver; Faehling, Martin; Fietz, Thomas; Fischer, Jürgen R.; Flieger, Dimitri; Freidt, Anke; Freier, Werner; Frenzel, Christian; Fuchs, Florian; Fuchs, Roswitha; Gaska, Tobias; Gleiber, Wolfgang; Grah, Christian; Grohé, Christian; Groschek, Matthias; Güldenzoph, Björn; Günther, Andreas; Haas, Siegfried; Hackenthal, Matthias; Hagen, Volker; Hahn, Lars; Hannig Carla, Verena; Hansen, Richard; Harich, Hanns-Detlev; Heilmann, Monika; Heinrich, Kathrin; Hering-Schubert, Christiane; Heßling, Jörg; Hoffknecht, Petra; Hortig, Patricia; Hübner, Gerdt; Hutzschenreuter, Ulrich; Illmer, Thomas; Innig, Georg; Junghanß, Christian; Kaiser, Ulrich; Kamal, Haytham; Kambartel, Kato; Kimmich, Martin; Kingreen, Dorothea; Kirchen, Heinz; Klausmann, Martine; Klein, Ortwin; Kokowski, Konrad; Körber, Wolfgang; Kortsik, Cornelius; Koschel, Dirk; Krämer, Benoit; Krammer-Steiner, Beate; Laack, Eckart; Lamberti, Christof; Leistner, Rumo David; Losem, Christoph; Lück, Andreas; Maintz, Christoph; Martin, Kerstin; Medgenberg, Dirk; Metzenmacher, Martin; Meyer zum Büschenfelde, Christian; Meyn, Philipp; Moorahrend, Enno; Müller, Annette; Müller, Lothar; Neise, Michael; Nückel, Holger; Nusch, Arnd; Overbeck, Tobias; Pelz, Henning; Peuser, Bettina; Plath, Margarete; Randerath, Winfried J.; Rauh, Jacqueline; Reck, Martin; Reichert, Dietmar; Reinmuth, Niels; Reiser, Marcel; Repp, Roland; Reschke, Daniel; Rittmeyer, Achim; Rodemer, Yolanda; Sackmann, Sandra; Sadjadian, Parvis; Sandner, Reiner; Sauer, Annette; Schäfer, Harald; Schaudt, Christoph; Schlag, Rudolf; Schmidt, Burkhard; Schmitz, Stephan; Schroeder, Michael; Schulze, Mathias; Schumann, Christian; Schütte, Wolfgang; Schwaiblmair, Martin; Schwindt Peter, Florian; Seese, Bernd; Seipelt, Gernot; Sorgenfrei, Thomas; Steiff, Johannes; Steiniger, Heike; Trarbach, Tanja; Tufman, Amanda; Uhlig, Jens; Vehling-Kaiser, Ursula; von der Heyde, Eyck; von Verschuer, Ulla; Waller, Cornelius; Wehler, Thomas; Weißenborn, Georg; Weißinger, Florian; Wermke, Martin; Wiegand, Jörg; Wilhelm, Stefan; Zahn, Mark-Oliver; Zaiss, Matthias; Zeth, Matthias; Dörfel, Steffen; Griesinger, Frank; Hummel, Horst-Dieter; Jaeschke, Bastian; Kern, Jens; Petersen, Volker; Schröder, Jan; Sebastian, Martin; Wesseler, Claas; Wilke, Jochen
    Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)
    In: JTO Clinical and Research Reports , Jg. 5 2024, Nr. 4, 100626
    DOI (Open Access)
  • Ballhausen, A.; Karthaus, M.; Fruehauf, S.; Graeven, U.; Müller, L.; König, A.O.; von Weikersthal, L.F.; Sommerhäuser, G.; Jelas, I.; Alig, A.H.S.; Kurreck, A.; Stahler, A.; Goekkurt, E.; Held, S.; Kasper, Stefan; Heinrich, K.; Heinemann, V.; Stintzing, S.; Trarbach, Tanja; Modest, D.P.
    Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction : A prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial
    In: ESMO Open , Jg. 9 2024, Nr. 7, 103628
    DOI (Open Access)
  • Stahler, Arndt; Kind, Andreas J.; Sers, Christine; Mamlouk, Soulafa; Müller, Lothar; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Sommerhäuser, Greta; Kasper, Stefan; Hoppe, Beeke; Kurreck, Annika; Held, Swantje; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P.
    Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212)
    In: Clinical Cancer Research , Jg. 30 2024, Nr. 7, S. 1256 – 1263
    DOI
  • Sommerhäuser, Greta; Karthaus, Meinolf; Kurreck, Annika; Ballhausen, Alexej; Meyer-Knees, Johanna W.; Fruehauf, Stefan; Graeven, Ullrich; Mueller, Lothar; Koenig, Alexander O.; Fischer V. Weikersthal, Ludwig; Goekkurt, Eray; Haas, Siegfried; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Alig, Annabel H. S.; Kasper-Virchow, Stefan; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P.
    Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer : Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212)
    In: International Journal of Cancer , Jg. 154 2024, Nr. 5, S. 863 – 872
    DOI (Open Access)
  • Stahler, Arndt; Hoppe, Beeke; Na, Il-Kang; Keilholz, Luisa; Müller, Lothar; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Fischer Von Weikersthal, Ludwig; Goekkurt, Eray; Kasper, Stefan; Kind, Andreas Jay; Kurreck, Annika; Alig, Annabel Helga Sophie; Held, Swantje; Reinacher-Schick, Anke; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) , Jg. 41 2023, Nr. 16, S. 2975 – 2987
    DOI
  • Sommerhäuser, Greta; Kurreck, Annika; Beck, Alexander; Fehrenbach, Uli; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Mueller, Lothar; Koenig, Alexander O.; v. Weikersthal, Ludwig F.; Goekkurt, Eray; Haas, Siegfried; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Alig, Annabel H.S.; Kasper, Stefan; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P.
    Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer : An analysis of the PanaMa trial (AIO KRK 0212)
    In: European Journal of Cancer (EJC) , Jg. 178 2023, S. 37 – 48
    DOI
  • Ballhausen, Alexej; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Sommerhäuser, Greta; Alig, Annabel Helga Sophie; Goekkurt, Eray; Meyer-Knees, Johanna Wanda; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Kasper, Stefan; Heinrich, Kathrin; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy : A prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial
    In: European Journal of Cancer (EJC) , Jg. 190 2023, 112955
    DOI
  • Heinrich, K.; Karthaus, M.; Fruehauf, S.; Graeven, U.; Mueller, L.; König, A.O.; von Weikersthal, L. Fischer; Caca, K.; Kretzschmar, A.; Goekkurt, E.; Haas, S.; Alig, A.H.S.; Kurreck, A.; Stahler, A.; Held, S.; Sommerhäuser, G.; Heinemann, V.; Stintzing, S.; Trarbach, Tanja; Modest, D.P.
    Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). : Subgroup analysis of the PanaMa-study (AIO-KRK-0212)
    In: ESMO Open , Jg. 8 2023, Nr. 4, 101568
    DOI (Open Access)
  • Griesinger, Frank; Hummel, Horst-Dieter; Schäfer, Harald; de Wit, Maike; Kaiser, Ulrich; Kern, Jens; Jänicke, Martina; Spring, Lisa; Zacharias, Stefan; Kaiser-Osterhues, Anja; Groth, Annika; Hipper, Annette; Zaun, Gregor; Müller, Lothar; Uhlig, Jens; Thomas, Michael; Sebastian, Martin; Eberhardt, Wilfried; Ababei, Juliana; Alt, Jürgen; Ammon, Andreas; Anhuf, Jürgen; Azeh, Ivo; Bauer, Stefan; Behringer, Dirk; Berger, Winfried; Bernhardt, Christiane; Bertram, Mathias; Boesche, Michael; Bohnet, Sabine; Bruch, Harald-Robert; Brückl, Wolfgang; Burkhard-Meier, Ulrike; Christopoulos, Petros; Däßler, Klaus-Ulrich; Dechow, Tobias; Depenbusch, Reinhard; Dietze, Lutz; Dommach, Markus; Dörfel, Steffen; Elender, Corinna; Elsel, Wolfgang; Emde, Till-Oliver; Faehling, Martin; Fietz, Thomas; Fischer, Jürgen R.; Flieger, Dimitri; Freidt, Anke; Freier, Werner; Frenzel, Christian; Fuchs, Florian; Fuchs, Roswitha; Gaska, Tobias; Gleiber, Wolfgang; Grah, Christian; Grohé, Christian; Groschek, Matthias; Güldenzoph, Björn; Günther, Andreas; Haas, Siegfried; Hackenthal, Matthias; Hagen, Volker; Hahn, Lars; Hannig, Carla Verena; Hansen, Richard; Harich, Hanns-Detlev; Heilmann, Monika; Heinrich, Kathrin; Hering-Schubert, Christiane; Heßling, Jörg; Hoffknecht, Petra; Hortig, Patricia; Hübner, Gerdt; Hutzschenreuter, Ulrich; Illmer, Thomas; Innig, Georg; Jaeschke, Bastian; Junghanß, Christian; Kamal, Haytham; Kambartel, Kato; Kimmich, Martin; Kingreen, Dorothea; Kirchen, Heinz; Klausmann, Martine; Klein, Ortwin; Kokowski, Konrad; Körber, Wolfgang; Kortsik, Cornelius; Koschel, Dirk; Krämer, Benoit; Krammer-Steiner, Beate; Laack, Eckart; Lamberti, Christof; Leistner, Rumo David; Losem, Christoph; Lück, Andreas; Maintz, Christoph; Martin, Kerstin; Medgenberg, Dirk; Metzenmacher, Martin; Meyer zum Büschenfelde, Christian; Meyn, Philipp; Moorahrend, Enno; Müller, Annette; Neise, Michael; Nückel, Holger; Nusch, Arnd; Overbeck, Tobias; Pelz, Henning; Petersen, Volker; Peuser, Bettina; Plath, Margarete; Randerath, Winfried J.; Rauh, Jacqueline; Reck, Martin; Reichert, Dietmar; Reinmuth, Niels; Reiser, Marcel; Repp, Roland; Reschke, Daniel; Rittmeyer, Achim; Rodemer, Yolanda; Sackmann, Sandra; Sadjadian, Parvis; Sandner, Reiner; Sauer, Annette; Schaudt, Christoph; Schlag, Rudolf; Schmidt, Burkhard; Schmitz, Stephan; Schröder, Jan; Schroeder, Michael; Schulze, Mathias; Schumann, Christian; Schütte, Wolfgang; Schwaiblmair, Martin; Schwindt, Peter Florian; Seese, Bernd; Seipelt, Gernot; Sorgenfrei, Thomas; Steiff, Johannes; Steiniger, Heike; Trarbach, Tanja; Tufman, Amanda; Vehling-Kaiser, Ursula; von der Heyde, Eyck; von Verschuer, Ulla; Waller, Cornelius; Wehler, Thomas; Weißenborn, Georg; Weißinger, Florian; Wermke, Martin; Wesseler, Claas; Wiegand, Jörg; Wilhelm, Stefan; Wilke, Jochen; Zahn, Mark-Oliver; Zaiss, Matthias; Zeth, Matthias
    Prognostic factors in nonsmall cell lung cancer : insights from the German CRISP registry
    In: European Respiratory Journal (ERJ) , Jg. 61 2023, Nr. 2, 2201336
    DOI (Open Access)
  • Modest, Dominik Paul; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja
    Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer : The Randomized PANAMA Trial (AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 1, S. 72 – 82
    DOI (Open Access)
  • Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin
    Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus : mature results of a phase I/II trial
    In: Radiation Oncology , Jg. 16 2021, Nr. 1, S. 59
    DOI, Online Volltext (Open Access)
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Höhler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Reis, Henning; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kostbade, Karina; Virchow, Isabel; Ting, Saskia; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Wiesweg, Marcel; Schuler, Martin; Trarbach, Tanja
    Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer : The CEBIFOX Trial
    In: Clinical Colorectal Cancer , Jg. 19 2020, Nr. 4, S. 236 – 247.e6
    DOI
  • Kasper, Stefan; Reis, Henning; Ziegler, Sophie; Nothdurft, Silke; Mueller, Andre; Goetz, Moritz; Wiesweg, Marcel; Phasue, Jeannette; Ting, Saskia; Wieczorek, Sarah; Even, Anna; Worm, Karl; Pogorzelski, Michael; Breitenbuecher, Sandra; Meiler, Johannes; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Breitenbücher, Frank; Schuler, Martin
    Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy
    In: OncoTarget , Jg. 8 2017, Nr. 28, S. 45898 – 45917
    DOI (Open Access)
  • Reimer, P.; Höhler, T.; Schuler, Martin; Markus, P.; Knipp, Heike; Schumacher, B.; Dechene, Alexander; Ting, Saskia; Kasper, S.; Meiler, Johannes; Kostbade, K.; Berger, W.; Herold, T.; Trarbach, Tanja; Linden, G.; Steinmetz, H.T.; Schmid, Kurt Werner; Worm, K.; Paul, A.
    Cetuximab biweekly (q2w) plus mFOLFOX6 as 1st line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) – Primary endpoint and subgroup analysis of the CEBIFOX trial
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl.6, S. 508P
    DOI
  • Modest, D.P.; Kasper, Stefan; Stintzing, S.; Prasnikar, N.; Müller, L.; Caca, K.; Gökkurt, E.; von Weikersthal, L. Fischer; Kopp, H.-G.; Trarbach, Tanja
    Randomized phase II study of maintenance treatment with 5-FU/FA plus panitumumab vs 5-FU/FA alone after induction (mFOLFOX6 plus panitumumab) in patients with RAS WT metastatic colorectal cancer
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6, S. 605TiP
    DOI
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hoehler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Ting, Saskia; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kosbade, Karina; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) : Primary endpoint and subgroup analysis of the CEBIFOX trial
    In: Journal of Clinical Oncology (JCO) , Jg. 33 2015, Nr. 15 Suppl., S. 3568
    DOI
  • Folprecht, Gunnar; Hamann, Susanne; Schütte, Katharina; Trarbach, Tanja; Stoehlmacher-Williams, Jan; Ehninger, Gerhard
    Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer
    In: BMC Cancer , Jg. 14 2014, Nr. 1, S. 521
    DOI (Open Access)
  • Malka, David; Cervera, Pascale; Foulon, Stéphanie; Trarbach, Tanja; Fouchardière, Christelle de la; Boucher, Eveline; Fartoux, Laetitia; Faivre, Sandrine; Blanc, Jean-Frédéric; Viret, Frédéric; Assenat, Eric; Seufferlein, Thomas; Herrmann, Thomas; Grenier, Julien; Hammel, Pascal; Dollinger, Matthias; André, Thierry; Hahn, Philipp; Heinemann, Volker; Rousseau, Vanessa; Ducreux, Michel; Pignon, Jean-Pierre; Wendum, Dominique; Rosmorduc, Olivier; Greten, Tim F.
    Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO) : a randomised, open-label, non-comparative phase 2 trial
    In: The Lancet Oncology , Jg. 15 2014, Nr. 8, S. 819 – 828
    DOI
  • Folprecht, G; Gruenberger, T; Bechstein, W; Raab, H-R; Weitz, J; Lordick, F; Hartmann, J T; Stoehlmacher-Williams, J; Lang, H; Trarbach, Tanja; Liersch, T; Ockert, D; Jaeger, D; Steger, U; Suedhoff, T; Rentsch, A; Köhne, C-H
    Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)
    In: Annals of Oncology , Jg. 25 2014, Nr. 5, S. 1018 – 1025
    DOI
  • Folprecht, G.; Gruenberger, T.; Bechstein, W.; Raab, H. R.; Weitz, J.; Lordick, F.; Hartmann, J. T.; Lang, H.; Trarbach, Tanja; Stoehlmacher-Williams, J.; Liersch, T.; Ockert, D.; Jaeger, D.; Steger, U.; Suedhoff, T.; Kohne, C. H.
    Cetuximab and chemotherapy in the treatment of patients with initially “nonresectable” colorectal (CRC) liver metastases : Long-term follow-up of the CELIM trial.
    In: Journal of Clinical Oncology (JCO) , Jg. 31 S 2013, Nr. 15, S. 3538
    DOI
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hoehler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Ting, Saskia; Markus, P.; Paul, Andreas; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) : An interim analysis of the CEBIFOX trial
    In: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 15 Suppl., S. e14502
    DOI
  • Malka, D.; Cervera, P.; Heurteau-Foulon, S.; Wendum, D.; Trarbach, Tanja; De La Fouchardiere, C.; Boucher, E.; Fartoux, L.; Faivre, S. J.; Pignon, J. P.; Rosmorduc, O.; Greten, T. F.
    Gemcitabine and oxaliplatin (GEMOX) alone or with cetuximab in first-line treatment of advanced biliary cancers (ABC) : Exploratory analyses according to tumor KRAS/BRAF mutations and EGFR expression in a randomized phase II trial (BINGO)
    In: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 15 Suppl., S. 4127
    DOI
  • Wilson, P.M.; Yang, D.; Azuma, M.; Shi, M.M.; Danenberg, K.D.; Lebwohl, D.; Sherrod, A.; Ladner, R.D.; Zhang, W.; Danenberg, P.V.; Trarbach, Tanja; Folprecht, G.; Meinhardt, G.; Lenz, H.-J.
    Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib)
    In: The Pharmacogenomics Journal , Jg. 13 2013, Nr. 5, S. 410 – 416
    DOI
  • Kaiser, Gernot Maximil; Paul, Andreas; Sgourakis, George; Molmenti, Ernesto P.; Dechene, Alexander; Trarbach, Tanja; Stuschke, Martin; Baba, Hideo Andreas; Gerken, Guido; Sotiropoulos, Georgios
    Novel prognostic scoring system after surgery for klatskin tumor
    In: The American Surgeon / Southeastern Surgical Congress (SESC) (Hrsg.) , Jg. 79 2013, Nr. 1, S. 90 – 95
  • Kasper, Stefan; Breitenbücher, Frank; Reis, Henning; Brandau, Sven; Worm, K.; Köhler, J.; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Schuler, Martin
    Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade
    In: Oncogene , Jg. 32 2013, Nr. 23, S. 2873 – 2881
    DOI
  • Trarbach, Tanja; Przyborek, Marta; Schleucher, Norbert; Heeger, Steffen; Lüpfert, Christian; Vanhoefer, Udo
    Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomas
    In: Investigational New Drugs: The Journal of New Anticancer Agents , Jg. 31 2013, Nr. 3, S. 642 – 652
    DOI
  • Moehler, Markus; Gockel, Ines; Roessler, Hans-Peter; Arnold, Dirk; Trarbach, Tanja; Thomaidis, Thomas; Klautke, Gunther; Rödel, Claus; Brenner, Baruch; Lang, Hauke; Galle, Peter R.; Schimanski, Carl C.; Schmidberger, Heinz
    Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction
    In: BMC Cancer , Jg. 13 2013, S. 75
    DOI (Open Access)
  • Schuler, Martin; Zvirbule, Z.; Lordick, F.; Krilova, A.; Helbig, U.; Schulze-Bergkamen, H.; Thuss-Patience, P. C.; von Wichert, G.; Schulmann, K.; Trarbach, Tanja; Bauer, Sebastian; Mueller, C.; Al-Batran, S. E.; Huber, C.; Sahin, U.; Tureci, O.
    Safety, tolerability, and efficacy of the first-in-class antibody IMAB362 targeting claudin 18.2 in patients with metastatic gastroesophageal adenocarcinomas
    In: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 15 Suppl., S. 4080
    DOI
  • Trarbach, Tanja; Schultheis, Beate; Gauler, Thomas; Schneider, Vesile; Strumberg, Dirk; Eberhardt, Wilfried; Le Scouiller, Stephanie; Marotti, Marcelo; Brown, Kathryn H.; Drevs, Joachim
    Phase i open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours
    In: Investigational New Drugs: The Journal of New Anticancer Agents , Jg. 30 2012, Nr. 5, S. 1962 – 1971
    DOI
  • Kasper, Stefan; Reis, Henning; Breitenbücher, Frank; Markowetz, J.; Pogorzelski, M.; Trarbach, Tanja; Worm, K.; Schmid, Kurt Werner; Schuler, Martin
    Targeting the anti-apoptotic protein BCL-XL to overcome RAS mediated resistance to anti-EGFR antibody therapy in colorectal cancer
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 253
  • Oezcelik, Arzu; Kaiser, Gernot Maximil; Niebel, Wolfgang; Sleyman, Christopher; Treckmann, Jürgen-Walter; Sotiropoulos, Georgios; Reinhardt, Renate; Trarbach, Tanja; Malamutmann, Eugen; Paul, Andreas
    Ten-year survival of esophageal cancer after an en-bloc esophagectomy
    In: Journal of Surgical Oncology , Jg. 105 2012, Nr. 3, S. 284 – 287
    DOI
  • Weißhardt, Philipp; Trarbach, Tanja; Dürig, Jan; Paul, Andreas; Reis, Henning; Tilki, Derya; Miroschnik, Inna; Ergün, Süleyman; Klein, Diana
    Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab
    In: Histochemistry and Cell Biology , Jg. 137 2012, Nr. 3, S. 391 – 401
    DOI
  • Giatromanolaki, A.; Koukourakis, M. I.; Sivridis, E.; Gatter, K. C.; Trarbach, Tanja; Folprecht, G.; Shi, M. M.; Lebwohl, D.; Jalava, T.; Laurent, D.; Meinhardt, G.; Harris, A. L.
    Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials
    In: British Journal of Cancer (BJC) , Jg. 107 2012, Nr. 7, S. 1044 – 1050
    DOI (Open Access)
  • Karthaus, M.; Karapetis, C. S.; Brown, M.; Pavlakis, N.; Trarbach, Tanja; Marschner, N.; Duerk, H. A.; Manzione, L.; Pregabalin Study Grp
    A randomized, double-blind, placebo-controlled trial for prevention of oxaliplatin-induced neuropathy symptoms with pregabalin
    In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. Suppl. 4
  • Moehler, M.; Muller, A.; Hartmann, J. T.; Ebert, M.; Al-Batran, S. E.; Reimer, P.; Weihrauch, M.; Lordick, F.; Trarbach, Tanja; Biesterfeld, S.; Kabisch, M.; Wachtlin, D.; Galle, P. R.; AIO
    An open-label, multicenter biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
    In: Onkologie , Jg. 34 2011, Nr. Suppl. 6, S. 103 – 103
  • Moehler, M.; Mueller, A.; Hartmann, J.T.; Ebert, M.P.; Al-Batran, S.E.; Reimer, P.; Weihrauch, M.; Lordick, F.; Trarbach, Tanja; Biesterfeld, S.; Kabisch, M.; Wachtlin, D.; Galle, P.R.
    An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
    In: European Journal of Cancer (EJC) , Jg. 47 2011, Nr. 10, S. 1511 – 1520
    DOI
  • Gencer, Deniz; Tauchert, Felix; Keilhauer, Nina; Al-Batran, Salah-Eddin; Stahl, Michael; Oskay-Özcelik, Gülten; Hipp, Matthias; Leibbrand, Birgit; Prasnikar, Nicole; Trarbach, Tanja; Stoll, Christoph; Van Kampen, Michael; Hochhaus, Andreas; Lorenzen, Sylvie; Hofheinz, Ralf-Dieter
    Cancer Patients and the Internet : A Survey of the ‘Quality of Life’ Working Groups of the Arbeitsgemeinschaft für Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie
    In: Onkologie , Jg. 34 2011, Nr. 8-9, S. 435 – 440
    DOI
  • Gencer, D.; Tauchert, F.; Keilhauer, N.; Al-Batran, S. E.; Stahl, Michael; Oskay-Ozcelik, G.; Hipp, M.; Leibbrand, B.; Prasnikar, N.; Trarbach, Tanja; Stoll, C.; Hochhaus, A.; Lorenzen, S.; Hofheinz, R. D.
    Cancer patients and the internet - a survey of the quality of life working groups of the AIO and the NOGGO
    In: Onkologie , Jg. 34 2011, Nr. Suppl. 6, S. 42
  • Moehler, M.; Mueller, A.; Trarbach, Tanja; Lordick, F.; Seufferlein, T.; Kubicka, S.; Geißler, M.; Schwarz, S.; Galle, P.R.; Kanzler, S.
    Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer : A prospective multi-center biomarker-oriented phase II study
    In: Annals of Oncology , Jg. 22 2011, Nr. 6, S. 1358 – 1366
    DOI
  • Gkika, E.; Pöttgen, Christoph; Berkovic, Katharina; Abu Jawad, Jehad; Trarbach, Tanja; Stuschke, Martin
    Definitive Chemoradiotherapy in locally advanced cervical Carcinoma of the Esophagus
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 117
  • Livingstone, Elisabeth; Trarbach, Tanja; Zimmer, Lisa; Schuler, Martin; Schadendorf, Dirk
    EGFR-Inhibitoren und Multityrosinkinaseinhibitoren : Interdisziplinäre Behandlung der kutanen Nebenwirkungen
    In: Deutsche Medizinische Wochenschrift - DMW , Jg. 136 2011, Nr. 1-2, S. 39 – 44
    DOI
  • Potthoff, K.; Hofheinz, R.; Hassel, Christoph; Volkenandt, M.; Lordick, F.; Hartmann, J.T.; Karthaus, M.; Riess, H.; Lipp, H.P.; Hauschild, A.; Trarbach, Tanja; Wollenberg, A.
    Interdisciplinary management of EGFR-inhibitor-induced skin reactions : A German expert opinion
    In: Annals of Oncology , Jg. 22 2011, Nr. 3, S. 524 – 535
    DOI
  • Radunz, Sonia; Heuer, Matthias; Trarbach, Tanja; Mathe, Zoltan; Baba, Hideo Andreas; Paul, Andreas; Sotiropoulos, Georgios
    Long-term survival after "liver first" approach for locally advanced rectal cancer and synchronous liver metastases
    In: International Journal of Colorectal Disease , Jg. 26 2011, Nr. 9, S. 1219 – 1220
    DOI
  • Kasper, Stefan; Breitenbücher, Frank; Even, A.; Pogorzelski, M.; Hoffarth, S.; Stergar, S. L.; Trarbach, Tanja; Schuler, Martin
    Pharmacological Inhibition of NF-k and PLK-1 to the Opening of the RAS-mediated Resistance to anti-EGFR Antibody therapies in Colorectal cancer *
    In: Der Internist , Jg. 52 2011, Nr. 6, S. 726 – 726
  • Koukourakis, Michael I.; Giatromanolaki, Alexandra; Sivridis, Efthimios; Gatter, Kevin C.; Trarbach, Tanja; Folprecht, Gunnar; Shi, Michael M.; Lebwohl, David; Jalava, Tarja; Laurent, Dirk; Meinhardt, Gerold; Harris, Adrian L.
    Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy
    In: Clinical Cancer Research , Jg. 17 2011, Nr. 14, S. 4892 – 4900
    DOI
  • Hecht, J. Randolph; Trarbach, Tanja; Hainsworth, John D.; Major, Pierre; Jäger, Elke; Wolff, Robert A.; Lloyd-Salvant, Katherine; Bodoky, György; Pendergrass, Kelly; Berg, William; Chen, Bee-Lian; Jalava, Tarja; Meinhardt, Gerold; Laurent, Dirk; Lebwohl, David; Kerr, David
    Randomized, Placebo-Controlled, Phase III Study of First-Line Oxaliplatin-Based Chemotherapy Plus PTK787/ZK 222584, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Metastatic Colorectal Adenocarcinoma
    In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. 15, S. 1997 – 2003
    DOI
  • Welter, Stefan; Theegarten, Dirk; Trarbach, Tanja; Maletzki, Frank; Stamatis, Georgios; Tötsch, Martin
    Safety distance in the resection of colorectal lung metastases : A prospective evaluation of satellite tumor cells with immunohistochemistry
    In: The Journal of Thoracic and Cardiovascular Surgery , Jg. 141 2011, Nr. 5, S. 1218 – 1222
    DOI (Open Access)
  • Schuler, Martin; Breitenbücher, Frank; Trarbach, Tanja; Brandau, Sven; Schmid, Kurt Werner; Kasper, Stefan
    Simultaneous protection against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR-signaling blockade by oncogenic RAS
    In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. Suppl. 4, S. 440
    DOI
  • Karthaus, M.; Karapetis, C. S.; Brown, M. P.; Pavlakis, N.; Trarbach, Tanja; Marschner, N.; Duerk, H. A.; Barone, C.; Luigi, M.; Pregabalin-Study Group
    A randomized, double-blind, placebo-controlled trial for prevention of oxalipatin-induced peripheral neuropathy symptoms with pregabalin in patients with advanced colorectal cancer
    In: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. Suppl. 15, S. e19573
    DOI
  • Reinacher-Schick, Anke; Arnold, Dirk; Trarbach, Tanja; Ridwelski, Karsten; Bruch, Hans-Peter; Kirchner, Thomas; Kubicka, Stefan; Schmoll, Hans-Joachim
    Adjuvante Therapie des Kolonkarzinoms
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 4, S. 2 – 7
    DOI
  • Moehler, M. H.; Hartmann, J. T.; Lordick, F.; Al-Batran, S.; Reimer, P.; Trarbach, Tanja; Ebert, M. P.; Daum, S.; Weihrauch, M.; Galle, P. R.; Upper GI Group of German AIO
    An open-label, multicenter phase II trial of sunitinib for patients with chemorefractory metastatic gastric cancer
    In: Journal of Clinical Oncology (JCO) , Jg. 28 2010, Nr. Suppl. 15, S. e14503
    DOI
  • Trarbach, Tanja; Schneider, Andreas; Noppeney, Richard; Novotny, Jürgen; Moritz, Thomas; Dührsen, Ulrich; Seeber, Siegfried; Flasshove, Michael
    CD34-Subpopulations and Clonogenic Progenitors in Mobilized Peripheral Blood Cells from Patients with Acute Myeloid Leukemia
    In: TumorDiagnostik & Therapie , Jg. 31 2010, S. 269 – 275
    DOI
  • Trarbach, Tanja; Reinacher-Schick, Anke; Hegewisch-Becker, Susanne; Vanhoefer, Udo Joachim; Frieling, Thomas; Lehnert, Lasse; Schmiegel, Wolff; Graeven, Ullrich
    Gefitinib in combination with capecitabine as second-line therapy in patients with advanced colorectal cancer (aCRC) : a phase I/II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
    In: Onkologie , Jg. 33 2010, Nr. 3, S. 89 – 93
    DOI
  • Trarbach, Tanja; Moehler, Markus; Heinemann, Volker; Köhne, Claus-Henning; Przyborek, Marta; Schulz, Christoph; Sneller, Vesna; Gallant, Gilles; Kanzler, Stefan
    Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
    In: British Journal of Cancer (BJC) , Jg. 102 2010, Nr. 3, S. 506 – 512
    DOI (Open Access)
  • Arnold, Dirk; Schmoll, Hans-Joachim; Lang, Hauke; Knoefel, Wolfram Trudo; Ridwelski, Karsten; Trarbach, Tanja; Staib, Ludger; Kirchner, Thomas; Geißler, Michael; Seufferlein, Thomas; Amthauer, Holger; Riess, Hanno; Schlitt, Hans J.; Piso, Pompiliu
    Spezielle Therapiesituationen beim metastasierten kolorektalen Karzinom
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 4, S. 8 – 18
    DOI
  • Kaiser, Gernot Maximil; Sotiropoulos, Georgios; Sgourakis, George; Bleck, Jessica; Baba, Hideo Andreas; Beckebaum, Susanne; Gerken, Guido; Paul, Andreas; Trarbach, Tanja
    Surgical treatment of Klatskin tumor : Liver resection versus transplantation
    In: Hepato-gastroenterology Journal , Jg. 57 2010, Nr. 104, S. 1337 – 1340
  • Juntermanns, Benjamin; Radünz, Sonia; Heuer, Matthias; Hertel, Sabine; Reis, Henning; Neuhaus, Jan Peter; Vernadakis, S.; Trarbach, Tanja; Paul, Andreas; Kaiser, Gernot Maximil
    Tumor markers as a diagnostic key for hilar cholangiocarcinoma
    In: European Journal of Medical Research , Jg. 15 2010, Nr. 8, S. 357 – 361
    DOI (Open Access)
  • Lang, Hauke; Sotiropoulos, Georgios; Sgourakis, George; Schmitz, Klaus Jürgen; Paul, Andreas; Hilgard, Philip Alexander; Zöpf, Thomas; Trarbach, Tanja; Malagó, Massimo; Baba, Hideo Andreas; Broelsch, Christoph E.
    Operations for Intrahepatic Cholangiocarcinoma : Single-Institution Experience of 158 Patients
    In: Journal of the American College of Surgeons , Jg. 208 2009, Nr. 2, S. 218 – 228
    DOI
  • Bockhorn, Maximilian; Sotiropoulos, Georgios; Neuhaus, Jan Peter; Sgourakis, George; Sheu, Sien-Yi; Molmenti, Ernesto; Fingas, Christian; Trarbach, Tanja; Frilling, Andreja; Broelsch, Christoph E.
    Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases
    In: International Journal of Colorectal Disease , Jg. 24 2009, Nr. 7, S. 845 – 850
    DOI
  • Vanhoefer, Udo Joachim; Tewes, Mitra; Rojo, Federico; Dirsch, Olaf; Schleucher, Norbert; Rosen, Oliver; Tillner, Joachim; Kovar, Andreas; Braun, Ada Henrike; Trarbach, Tanja; Seeber, Siegfried; Harstrick, Andreas; Baselga, José
    Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor
    In: Journal of Clinical Oncology , Jg. 22 2004, Nr. 1, S. 175 – 184
    DOI

    • Abstracts

  • Ballhausen, Alexej; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; Koenig, Alexander; Von Weikersthal, Ludwig Fischer; Sommerhäuser, Greta; Jelas, Ivan; Alig, Annabel Helga Sophie; Kurreck, Annika; Stahler, Arndt; Goekkurt, Eray; Held, Swantje; Kasper, Stefan; Heinrich, Kathrin; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Dermatology-related quality of life outcomes in patients with RAS wild-type (wt) metastatic colorectal cancer (mCRC) treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction : A prespecified secondary analysis of the phase 2 randomized PanaMa (AIO KRK 0212) trial
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, e15539
    DOI (Open Access)
  • Modest, Dominik Paul; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; Koenig, Alexander; Fischer von Weikersthal, Ludwig; Caca, Karel; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke C.; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Stahler, Arndt
    FU/FA maintenance therapy with or without panitumumab (pmab) in RAS wild-type metastatic colorectal cancer (mCRC) (PanaMa, AIO KRK 0212) : Updated efficacy analyses
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, 3506
    DOI (Open Access)
  • Hoppe, Beeke; Modest, Dominik Paul; Keilholz, Luisa; Na, Il-Kang; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Von Weikersthal, Ludwig Fischer; Goekkurt, Eray; Reinacher-Schick, Anke C.; Kasper, Stefan; Kind, Andreas Jay; Kurreck, Annika; Held, Swantje; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Stahler, Arndt
    Consensus molecular subtypes (CMS) as prognostic and predictive biomarkers of panitumumab (Pmab), fluorouracil and folinic acid (FU/FA) or FU/FA maintenance therapy following Pmab-FOLFOX induction in RAS wildtype metastatic colorectal cancer (mCRC) : PANAMA trial (AIO-KRK-0212)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 3537
    DOI
  • Kind, Andreas Jay; Modest, Dominik Paul; Sers, Christine; Mamlouk, Soulafa; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Von Weikersthal, Ludwig Fischer; Goekkurt, Eray; Reinacher-Schick, Anke C.; Kasper, Stefan; Kurreck, Annika; Hoppe, Beeke; Held, Swantje; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Stahler, Arndt
    Negative hyperselection for mutations associated with anti-EGFR antibody resistance in RAS wildtype metastatic colorectal cancer (mCRC) : Evaluation of the PANAMA trial (AIO-KRK-0212, maintenance therapy with 5-FU, folinic acid (FU/FA) with or without panitumumab)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 3536
    DOI
  • Kurreck, Annika; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Mueller, Lothar; Koenig, Alexander; von Weikersthal, Ludwig; Goekkurt, Eray; Haas, Siegfried; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Alig, Annabel Helga Sophie; Hoppe, Beeke; Kind, Andreas Jay; Kasper, Stefan; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Predictive and prognostic value of carcinoembryonic antigen (CEA) on maintenance therapy with 5-fluoruracil/leucovorin plus panitumumab or 5-fluoruracil/leucovorin alone in RAS wildtype metastatic colorectal cancer : Evaluation of the phase II PanaMa trial (AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 3587
    DOI (Open Access)
  • Raimondi, A.; Morano, F.; Trarbach, Tanja; Karthaus, M.; Lonardi, S.; Fruehauf, S.; Cremolini, C.; Graeven, U.; Bittoni, A.; Mueller, L.; Sartore Bianchi, A.; Aranda, E.; Boige, V.; Stintzing, S.; Di Bartolomeo, M.; Koenig, A.; Pietrantonio, F.; Modest, D.
    SO-21 Optimal maintenance treatment strategy following an anti-EGFR-based first-line induction therapy in patients with RAS wild type metastatic colorectal cancer : An individual patient data pooled analysis of clinical trials
    In: Annals of Oncology , Jg. 33 2022, Nr. Suppl. 4, S. 366
    DOI (Open Access)
  • Modest, Dominik Paul; Karthaus, Meinolf; Frühauf, Stefan; Graeven, Ullrich; Müller, Lothar; Koenig, Alexander; Von Weikersthal, Ludwig Fischer; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Jarosch, Armin; Horst, David; Kasper, Stefan; Stintzing, Sebastian; Trarbach, Tanja
    Maintenance therapy with 5-fluoruracil/leucovorin (5FU/LV) plus panitumumab (pmab) or 5FU/LV alone in RAS wildtype (WT) metastatic colorectal cancer (mCRC) - the PANAMA trial (AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 3503 – 3503
    DOI (Open Access)
  • Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin
    Prognostic Significance of the metabolic Response during Induction Chemotherapy for the definitive Chemoradiotherapy of locally advanced Squamous Cell Carcinoma of the Esophagus
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 154 – S155
  • Kasper, Stefan; Goetze, Thorsten Oliver; Stintzing, Sebastian; Hofheinz, Ralf Dieter; Sinn, Marianne; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Keitel, Verena; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Kolov, Alexander; Edelmann, Thomas; Stein, Alexander; Trarbach, Tanja; Junge, Sabine; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    RAMucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic colorectal cancer : Safety results from the phase IIb part of the RAMTAS phase II/III trial of the German AIO (AIO-KRK-0316)
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 3566 – 3566
    DOI (Open Access)
  • Kasper, Stefan; zur Hausen, Gerrit; Stein, Alexander; Stintzing, Sebastian; Berger, Andreas; Loges, Sonja; Hofheinz, Ralf; Trarbach, Tanja; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Goetze, Thorsten Oliver; Hagen, Volker A.; Burock, Susen; Hoffmeister, Albrecht; Dechow, Tobias Nicolaas; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients : The RAMTAS trial of the German AIO (KRK-0316)
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. TPS3617 – TPS3617
    DOI (Open Access)
  • Abendroth, A.; Markus, M.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan
    Evaluation of systemic inflammatory response (SIR) markers in advanced biliary tract cancer (ABTC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment , Jg. 38 2015, Nr. Suppl. 5, S. 5 – 6
    DOI
  • Markus, M.; Kasper, Stefan; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Abendroth, A.
    Evaluation of systemic inflammatory response (SIR) markers in pancreatic ductal adenocarcinoma (PDAC)
    In: Oncology Research and Treatment , Jg. 38 2015, Nr. S 5, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz, S. 4 – 5
    DOI
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hohler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Ting, Saskia; Markus, P.; Paul, Andreas; Dechene, Alexander; Kostbade, K.; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) - Primary endpoint analysis of the CEBIFOX trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 5, S. 99 – 100
    DOI
  • Kasper, Stefan; Ting, Saskia; Meiler, Johannes; Knipp, Heike; Hohler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Worm, K.; Schmid, Kurt Werner; Markus, P.; Paul, Andreas; Dechene, Alexander; Forsting, Michael; Kostbade, K.; Trarbach, Tanja; Schuler, Martin
    Molecular and clinical predictors of the efficacy of cetuximab in combination with mFOLFOX6 in 1st line treatment of patients (pts) with metastatic colorectal cancer (mCRC) : subgroup analyses of the CEBIFOX trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 5, S. 100 – 101
    DOI
  • Kasper, Stefan; Breitenbücher, Frank; Markowetz, J.; Reis, Henning; Ting, Saskia; Worm, K.; Meiler, Johannes; Schmid, Kurt Werner; Trarbach, Tanja; Schuler, Martin
    Molecular dissection of effector mechanisms of RAS-induced resistance to monoclonal anti-EGFR antibodies
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 116 – 117
    DOI
  • Abendroth, A.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Tometten, M.; Wiesweg, Marcel; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ), one of the 11 Oncology Centers of Excellence in Germany
    17 Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 263
    DOI
  • Folorecht, G.; Gruenberger, T.; Bechstein, W.; Raab, H. R.; Weitz, J.; Lordick, F.; Hartmann, J. T.; Lang, H.; Trarbach, Tanja; Stohlmacher, J.; Liersch, T.; Ockert, D.; Jager, D.; Steger, U.; Sudhoff, T.; Kohne, C. H.
    Survival of patients with initially non-resectable colorectal liver metastases following systemic treatment with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM-study)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 72 – 73
    DOI
  • Moehler, M.; Mueller, A.; Trarbach, Tanja; Lordick, F.; Seufferlein, T.; Kubicka, S.; Schwarz, S.; Galle, P. R.; Kanzler, S.; AIO
    Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer : A prospective multi-center biomarker-oriented phase II study
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 116
    DOI
  • Pöttgen, Christoph; Gkika, Eleni; Berkovic, Katharina; Kaelberlah, Hans-Peter; Abu Jawad, Jehad; Trarbach, Tanja; Gauler, Thomas; Stahl, Michael; Stuschke, Martin
    Dosisgesteigerte Strahlentherapie nach PET/CT-Planung in Kombination mit Induktions- und Simultaner Chemotherapie bei lokal fortgeschrittenen Platten-epithelkarzinomen (uT3/T4) des Ösophagus : Ergebnisse einer Phase I/II Studie (SPOT)
    16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. Suppl. 1, S. 48
    DOI
  • Even, A.; Kasper, Stefan; Breitenbucher, F.; Pogorzelski, M.; Hoffarth, S.; Trarbach, Tanja; Schuler, Martin
    Targeting NF-kappa B and PLK-1 to overcome RAS-mediated resistance to anti-EGFR antibody therapy in colorectal cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 33
    DOI

    • Bücher/Sammelwerke/Tagungsbände

  • Trarbach, Tanja
    Zielgerichtete Therapieansätze bei der Behandlung fortgeschrittener gastrointestinaler Tumore
    Duisburg ; Essen 2019

    • Poster / Posterbeiträge

  • Stahler, Arndt; Hoppe, Beeke; Keilholz, Luisa; Na, Il-Kang; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Fischer Von Weikersthal, Ludwig; Kasper, Stefan; Ballhausen, Alexej; Sommerhäuser, Greta; Alig, Annabel Helga Sophie; Kurreck, Annika; Held, Swantje; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Combined amphiregulin and epiregulin expression as a prognostic and predictive biomarker of panitumumab (Pmab), fluorouracil, and folinic acid (FU/FA) or FU/FA maintenance therapy following Pmab+FOLFOX induction in RAS wildtype metastatic colorectal cancer (mCRC) : PANAMA trial (AIO-KRK-0212)
    2024 ASCO Annual Meeting, May 31 - June 4, 2024, Online und Chicago, IL, USA,
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, 3528
    DOI
  • Hilger, Ralf A.; Köhler, Jens; Kalkavan, H.; Richly, Heike; Hoffmann, Andreas-Claudius; Heinrichs, D.; Azaouagh, A.; Schuler, Martin; Trarbach, Tanja
    Interpatient pharmacokinetic variability of 5-FU within metastatic and adjuvant colon cancer patients : First results from the West German Cancer Center
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 173
    DOI